TP53 and serous adenocarcinoma: Immunohistochemically, SEIC is characterized by a mutation-type p53 pattern; this reflects the presence of underlying TP53 mutation and can also be observed in the earliest precursor of serous carcinoma, i.e., the so-called p53 signature [13].